Kwong Lung Enterprise Co., Ltd. (TPEX:8916)
47.60
-0.25 (-0.52%)
Apr 28, 2026, 1:30 PM CST
Kwong Lung Enterprise Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 8,538 | 7,893 | 7,708 | 10,304 | 8,061 | Upgrade
|
| Revenue Growth (YoY) | 8.17% | 2.40% | -25.19% | 27.83% | -5.16% | Upgrade
|
| Cost of Revenue | 7,228 | 6,528 | 6,326 | 8,541 | 7,072 | Upgrade
|
| Gross Profit | 1,310 | 1,365 | 1,382 | 1,763 | 988.66 | Upgrade
|
| Selling, General & Admin | 745.73 | 727.08 | 681.46 | 749.08 | 674.32 | Upgrade
|
| Research & Development | 55.62 | 50.99 | 53.07 | 50.91 | 48.82 | Upgrade
|
| Operating Expenses | 835.16 | 788.76 | 784.9 | 809.49 | 800.8 | Upgrade
|
| Operating Income | 474.61 | 576.64 | 597.23 | 953.71 | 187.87 | Upgrade
|
| Interest Expense | -50.42 | -35.57 | -25.34 | -20.96 | -13.92 | Upgrade
|
| Interest & Investment Income | 48.96 | 57.73 | 61.24 | 37.61 | 23.12 | Upgrade
|
| Earnings From Equity Investments | -20.66 | -13.79 | 23.06 | 25.77 | 118.75 | Upgrade
|
| Currency Exchange Gain (Loss) | -54.14 | 58.49 | 28.37 | 207.3 | -28.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 48.61 | 8.7 | 63.14 | -86.74 | -8.17 | Upgrade
|
| EBT Excluding Unusual Items | 446.95 | 652.2 | 747.71 | 1,117 | 278.91 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.8 | 83.4 | - | -8.73 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 59.72 | -0.07 | -1.29 | 23.13 | 332.27 | Upgrade
|
| Other Unusual Items | - | 6.25 | - | - | - | Upgrade
|
| Pretax Income | 507.47 | 741.78 | 746.42 | 1,131 | 611.18 | Upgrade
|
| Income Tax Expense | 130.34 | 135.38 | 169.27 | 213.6 | 121.43 | Upgrade
|
| Earnings From Continuing Operations | 377.13 | 606.4 | 577.15 | 917.49 | 489.75 | Upgrade
|
| Minority Interest in Earnings | 0.21 | 2.89 | 0.55 | 1.6 | 25.54 | Upgrade
|
| Net Income | 377.34 | 609.29 | 577.7 | 919.08 | 515.29 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.73 | 0.87 | 2.85 | 45.5 | 45.5 | Upgrade
|
| Net Income to Common | 376.61 | 608.42 | 574.84 | 873.58 | 469.79 | Upgrade
|
| Net Income Growth | -38.07% | 5.47% | -37.14% | 78.36% | 49.62% | Upgrade
|
| Shares Outstanding (Basic) | 151 | 151 | 146 | 134 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 152 | 152 | 152 | 151 | 150 | Upgrade
|
| Shares Change (YoY) | 0.19% | 0.22% | 0.51% | 0.49% | 0.11% | Upgrade
|
| EPS (Basic) | 2.50 | 4.04 | 3.93 | 6.54 | 3.58 | Upgrade
|
| EPS (Diluted) | 2.47 | 4.00 | 3.79 | 5.79 | 3.13 | Upgrade
|
| EPS Growth | -38.25% | 5.54% | -34.54% | 84.98% | 57.29% | Upgrade
|
| Free Cash Flow | 930.12 | -250.78 | 987.67 | 1,317 | -803.49 | Upgrade
|
| Free Cash Flow Per Share | 6.11 | -1.65 | 6.51 | 8.73 | -5.35 | Upgrade
|
| Dividend Per Share | 2.500 | 3.600 | 3.600 | 4.000 | 3.000 | Upgrade
|
| Dividend Growth | -30.56% | - | -10.00% | 33.33% | - | Upgrade
|
| Gross Margin | 15.34% | 17.30% | 17.93% | 17.11% | 12.26% | Upgrade
|
| Operating Margin | 5.56% | 7.31% | 7.75% | 9.26% | 2.33% | Upgrade
|
| Profit Margin | 4.41% | 7.71% | 7.46% | 8.48% | 5.83% | Upgrade
|
| Free Cash Flow Margin | 10.89% | -3.18% | 12.81% | 12.78% | -9.97% | Upgrade
|
| EBITDA | 609.36 | 695.81 | 716.01 | 1,081 | 330.22 | Upgrade
|
| EBITDA Margin | 7.14% | 8.82% | 9.29% | 10.49% | 4.10% | Upgrade
|
| D&A For EBITDA | 134.75 | 119.17 | 118.78 | 127.61 | 142.36 | Upgrade
|
| EBIT | 474.61 | 576.64 | 597.23 | 953.71 | 187.87 | Upgrade
|
| EBIT Margin | 5.56% | 7.31% | 7.75% | 9.26% | 2.33% | Upgrade
|
| Effective Tax Rate | 25.69% | 18.25% | 22.68% | 18.88% | 19.87% | Upgrade
|
| Advertising Expenses | - | - | - | - | 360.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.